Prediction of heart failure outcomes in patients with type 2 diabetes mellitus: Validation of the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes ( TRS‐HF DM ) in patients in the ACCORD trial-Reference-Cited by-同舟云学术

Prediction of heart failure outcomes in patients with type 2 diabetes mellitus: Validation of the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes ( TRS‐HF DM ) in patients in the ACCORD trial

Published:2021-01-05 Issue:3 Volume:23 Page:782-790
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Elharram Malik¹^ORCID,Ferreira João Pedro²^ORCID,Huynh Thao³,Ni Jiayi¹³,Giannetti Nadia¹,Verma Subodh⁴,Zannad Faiez²,Sharma Abhinav¹⁵

Affiliation:

1. Division of Cardiology McGill University Health Centre Montreal Quebec Canada

2. Université de Lorraine, Centre D'Investigation Clinique‐ Plurithématique Inserm CIC‐P 1433, Inserm U1116, CHRU Nancy Hopitaux de Brabois, F‐CRIN INI‐CRCT (Cardiovascular and Renal Clinical Trialists) Nancy France

3. Montreal General Hospital Montreal Quebec Canada

4. Division of Cardiac Surgery Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto Toronto Ontario Canada

5. DREAM‐CV Lab McGill University Health Centre Montreal Quebec Canada

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14283

Reference26 articles.

1. Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure

2. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death